| RHOA |
RHOA, ARH12, ARHA, RHO12: Transforming protein RhoA precursor |
PCBP1 |
PCBP1: Poly(rC)-binding protein 1 |
0.265 |
Evidence |
|
| ACTR3 |
ACTR3, ARP3: Actin-related protein 3 |
RHOA |
RHOA, ARH12, ARHA, RHO12: Transforming protein RhoA precursor |
0.265 |
Evidence |
|
| CXCR4 |
CXCR4: C-X-C chemokine receptor type 4 |
CD69 |
CD69: Early activation antigen CD69 |
0.265 |
Evidence |
|
| ACTG1 |
ACTB: Actin, cytoplasmic 1 |
RHOA |
RHOA, ARH12, ARHA, RHO12: Transforming protein RhoA precursor |
0.265 |
Evidence |
|
| EIF3S6 |
EIF3S6, INT6: Eukaryotic translation initiation factor 3 subunit 6 |
FUBP1 |
IPI00375441 |
0.265 |
Evidence |
|
| EIF3S9 |
EIF3S9: Eukaryotic translation initiation factor 3 subunit 9 |
DNMT1 |
DNMT1, AIM, DNMT: DNA |
0.265 |
Evidence |
|
| EIF3S9 |
EIF3S9: Eukaryotic translation initiation factor 3 subunit 9 |
UBAP2L |
UBAP2L, KIAA0144, NICE4: Ubiquitin-associated protein 2-like |
0.265 |
Evidence |
|
| EIF3S9 |
EIF3S9: Eukaryotic translation initiation factor 3 subunit 9 |
UBAP2 |
IPI00171127 |
0.265 |
Evidence |
|
| EIF3S9 |
EIF3S9: Eukaryotic translation initiation factor 3 subunit 9 |
PTMA |
IPI00015550 |
0.265 |
Evidence |
|
| EIF3S9 |
EIF3S9: Eukaryotic translation initiation factor 3 subunit 9 |
TRIM28 |
TRIM28, KAP1, RNF96, TIF1B: Transcription intermediary factor 1-beta |
0.265 |
Evidence |
|
| NAP1L1 |
NAP1L1, NRP: Nucleosome assembly protein 1-like 1 |
PTMA |
IPI00015550 |
0.265 |
Evidence |
|
| NAP1L1 |
NAP1L1, NRP: Nucleosome assembly protein 1-like 1 |
SET |
SET: Protein SET |
0.265 |
Evidence |
|
| NAP1L1 |
NAP1L1, NRP: Nucleosome assembly protein 1-like 1 |
GNB2L1 |
Lung cancer oncogene 7 |
0.265 |
Evidence |
|
| PSMD4 |
PSMD4, MCB1: 26S proteasome non-ATPase regulatory subunit 4 |
PTMA |
IPI00015550 |
0.265 |
Evidence |
|
| PSMD4 |
PSMD4, MCB1: 26S proteasome non-ATPase regulatory subunit 4 |
RBM3 |
RBM3, RNPL: Putative RNA-binding protein 3 |
0.265 |
Evidence |
|
| MFAP2 |
MFAP2, MAGP1: Microfibrillar-associated protein 2 precursor |
COL5A2 |
IPI00293881 |
0.265 |
Evidence |
|
| MFAP2 |
MFAP2, MAGP1: Microfibrillar-associated protein 2 precursor |
FSTL1 |
FSTL1, FRP: Follistatin-related protein 1 precursor |
0.265 |
Evidence |
|
| YARS |
YARS: Tyrosyl-tRNA synthetase, cytoplasmic |
TCOF1 |
IPI00298696 |
0.265 |
Evidence |
|
| YARS |
YARS: Tyrosyl-tRNA synthetase, cytoplasmic |
SET |
SET: Protein SET |
0.265 |
Evidence |
|
| RARS |
RARS: Arginyl-tRNA synthetase, cytoplasmic |
MAPK6 |
MAPK6, ERK3, PRKM6: Mitogen-activated protein kinase 6 |
0.265 |
Evidence |
|
| MSH6 |
MSH6, GTBP: DNA mismatch repair protein MSH6 |
TOP2A |
TOP2A, TOP2: DNA topoisomerase 2-alpha |
0.265 |
Evidence |
|
| MSH6 |
MSH6, GTBP: DNA mismatch repair protein MSH6 |
ESPL1 |
IPI00397474 |
0.265 |
Evidence |
|
| IRAK1 |
IRAK1, IRAK: Interleukin-1 receptor-associated kinase 1 |
RBM3 |
RBM3, RNPL: Putative RNA-binding protein 3 |
0.265 |
Evidence |
|
| IRAK1 |
IRAK1, IRAK: Interleukin-1 receptor-associated kinase 1 |
GNB2L1 |
Lung cancer oncogene 7 |
0.265 |
Evidence |
|
| SMARCA4 |
SMARCA4, BRG1, SNF2B, SNF2L4: Probable global transcription activator SNF2L4 |
DNMT1 |
DNMT1, AIM, DNMT: DNA |
0.265 |
Evidence |
|